Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytek Biosciences (CTKB) Prepaid Assets (2020 - 2025)

Historic Prepaid Assets for Cytek Biosciences (CTKB) over the last 6 years, with Q3 2025 value amounting to $18.5 million.

  • Cytek Biosciences' Prepaid Assets rose 4266.74% to $18.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.5 million, marking a year-over-year increase of 4266.74%. This contributed to the annual value of $14.1 million for FY2024, which is 1247.4% up from last year.
  • Cytek Biosciences' Prepaid Assets amounted to $18.5 million in Q3 2025, which was up 4266.74% from $15.1 million recorded in Q2 2025.
  • In the past 5 years, Cytek Biosciences' Prepaid Assets ranged from a high of $18.5 million in Q3 2025 and a low of $5.2 million during Q4 2021
  • Over the past 5 years, Cytek Biosciences' median Prepaid Assets value was $12.3 million (recorded in 2023), while the average stood at $11.7 million.
  • Per our database at Business Quant, Cytek Biosciences' Prepaid Assets soared by 14988.43% in 2022 and then crashed by 985.67% in 2023.
  • Quarter analysis of 5 years shows Cytek Biosciences' Prepaid Assets stood at $5.2 million in 2021, then surged by 149.88% to $13.0 million in 2022, then fell by 3.4% to $12.5 million in 2023, then grew by 12.47% to $14.1 million in 2024, then surged by 31.25% to $18.5 million in 2025.
  • Its last three reported values are $18.5 million in Q3 2025, $15.1 million for Q2 2025, and $14.5 million during Q1 2025.